← Back to Clinical Trials
Recruiting NCT06241963

NCT06241963 High Definition Transcranial Direct Current Stimulation (HD-tDCS) for Refractory Epilepsy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06241963
Status Recruiting
Phase
Sponsor Anhui Medical University
Condition Transcranial Direct Current Stimulation
Study Type INTERVENTIONAL
Enrollment 90 participants
Start Date 2024-02-12
Primary Completion 2025-12-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 50 Years
Study Type INTERVENTIONAL
Interventions
Active Comparator: Unilateral real High definition transcranial direct current stimulationActive Comparator: Bilateral real High definition transcranial direct current stimulationSham Comparator: Sham High definition transcranial direct current stimulation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 90 participants in total. It began in 2024-02-12 with a primary completion date of 2025-12-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

To observe the clinical effect and safety of transcranial electrical stimulation on patients with refractory epilepsy before and after treatment and analyze its therapeutic mechanism.

Eligibility Criteria

Inclusion Criteria: * Clinical diagnosis of refractory epilepsy * Right-handed and aged 18-50 years old and primary school education or above; * No major neurological or mental illness, no head injury, alcohol dependence or drug dependence; * During the experiment, the subjects did not smoke, drink, get sick and take psychotropic drugs, and there were no major life events that caused mood changes. Exclusion Criteria: * organic brain injury, neurological diseases or serious physical diseases; * Have a history of substance abuse and drug dependence, or have used antipsychotic drugs in the past three months, and have serious suicidal tendencies; * There are contraindications for MRI or EEG or transcranial magnetic stimulation.

Contact & Investigator

Central Contact

Kai Wang, PhD

✉ wangkai1964@126.com

📞 +86-0551-62923704

Frequently Asked Questions

Who can join the NCT06241963 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 50 Years, studying Transcranial Direct Current Stimulation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06241963 currently recruiting?

Yes, NCT06241963 is actively recruiting participants. Contact the research team at wangkai1964@126.com for enrollment information.

Where is the NCT06241963 trial being conducted?

This trial is being conducted at Hefei, China.

Who is sponsoring the NCT06241963 clinical trial?

NCT06241963 is sponsored by Anhui Medical University. The trial plans to enroll 90 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology